Scottish Provident is to rebrand with a new logo in blue and gold colours to signify the Scottish flag and gold standard service.
The group, which is owned by Resolution but operates an exclusive distribution deal through Abbey for Intermediaries, says the rebrand has been timed to coincide with the introduction of the ABI Statement of Best Practice on Critical Illness (CI) to minimise costs.
It says the new logo should dispel any rumours of a planned name change and demonstrates a commitment to the Scottish Provident brand by Resolution. This will be further reflected in the improvements being made to its service and e-business proposition.
The firm says the changes have been supported by Abbey for Intermediaries which has set up a specialist protection sales force to concentrate solely on Scottish Provident products sold through intermediaries.
Scottish Provident says this will allow it to focus on protection products in conjunction with specialist areas such as IHT and business protection, in addition to mortgage and personal protection.
And it says developments made to its CI definitions include the addition of cardiomyopathy, chronic lung disease, liver failure, traumatic head injury and progressive supranuclear palsy to its list as it believes these are a real issue for policyholders.
In addition, the firm says it is retaining its policy of no age limits on diseases like Alzheimer’s, Parkinson’s, Dementia and Motor Neurone Disease, while HIV exclusions have been removed from its disability income benefit on Income Protection (IP).
The firm also claims its changes offer more comprehensive cover to six existing definitions than those recommended by the ABI, such as keyhole surgery on coronary artery by-pass grafts.
Alison Turner Holmes, head of marketing, says : “The inclusion of new conditions is paramount to keeping up to date with medical progressions."
Scottish Provident also announced it declined almost 20% of critical illness (CI) claims in 2006, with more than half of these attributed to material non-disclosure.
Last year it paid out £95,537,741 in CI claims. This was a success rate of 80.3% as it declined 309 claims; 10.7% of which were because of material non-disclosure, and 9% because the illness did not meet the policy definitions.
The largest number of claims (57%) came from cancer sufferers, while 13% were related to heart attacks, 5% to multiple sclerosis, strokes accounted for 4% of claims, and 2% were related to heart surgery.
If you have any comments you would like to add to this story or would like to speak to its author about a similar subject, telephone Nyree Stewart on 020 7034 2681 or email [email protected]IFAonline
£300bn of liabilities
View from the front row
Transfer from occupational scheme
Appointed by FCA and PSR boards